About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

14729-D9831C00002- 1 Month Biopsy Study

NCT00766415·8 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

AstraZeneca

Age

40–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Men or women 40 years or above
FEV1 between 40 and 80% of predicted normal value post-bronchodilator
Clinical diagnosis of COPD

You may not be if

Other clinically relevant disease or disorders
Exacerbation of COPD within 30 days

The record

StatusCompleted

PhasePhase 2

Taking part52

StartedNov 2008

UpdatedFeb 28, 2014

Conditions

Chronic Obstructive Pulmonary Disease

Where8

Research Site
Frieburg, Germany
Research Site
Großhansdorf, Germany
Research Site
Hanover, Germany

Clareo Health | 14729-D9831C00002- 1 Month Biopsy Study